Immunomedics Announces

Related by string. * : Immunomedics NASDAQ IMMU . Immunomedics IMMU . PRNewswire FirstCall Immunomedics . CONTACT Immunomedics Inc. . GLOBE NEWSWIRE Immunomedics . Immunomedics / announc ed . ANNOUNCES . ANNOUNCE . announce . announces : Announces Second Quarter . Announces Third Quarter . Announces Fourth Quarter . Announce Partnership . Announces Launch . Announce Fourth Quarter * *

Related by context. Frequent words. (Click for all words.) 77 Drug Shows Promise 77 Meets Primary Endpoint 77 Improves Survival 77 Receives Orphan Drug Designation 76 Preclinical Data 76 Drug Candidate 75 Clinical Trial Results 75 Presents Positive 75 Patient Enrollment 75 MITTEILUNG UEBERMITTELT VON BUSINESS 74 Significantly Improved 74 Develop Novel 74 Arthritis Drug 74 Completes Enrollment 74 RNAi Therapeutics 74 Osteoporosis Drug 74 Reduces Risk 74 Initiates Phase II 73 FDA Accepts 73 Study Demonstrates 73 FDA Clears 73 Cholesterol Drug 73 Patent Issued 73 Announces FDA Clearance 73 CA BUSINESS 73 Commences Phase 73 Significantly Improves 73 #:#-# Abstract Free [009] 72 #:#-# Abstract Free [008] 72 Holds Promise 72 美 通 社 72 Single Dose 72 Phase III Clinical Trial 72 Drug Resistant 72 Achieves Milestone 72 Prostate Cancer Patients 72 Inhaled Insulin 72 #:#-# Abstract Free [006] 71 Blood Thinner 71 Clinical Trials Update 71 Obese Patients 71 #:#-# Abstract Free [005] 71 Key Milestones 71 Report Analyzes 71 Tumor Growth 71 Smallpox Vaccine 71 Small Molecule 71 Prostate Cancer Treatment 71 Patent Covering 71 Chronic Hepatitis C 71 Shows Promise 71 Provides Guidance 71 Gastric Cancer 71 Diagnostic Tests 71 Cervical Cancer Vaccine 71 Meta Analysis 71 Provides Shareholder 71 #-# Full Text 71 Enrolls First 70 Pivotal Phase 70 Currency Majors Technical 70 Grants Awarded 70 Cholesterol Drugs 70 Significantly Reduces 70 Mouse Model 70 Receives Patent 70 Jumps Higher 70 Monoclonal Antibody 70 Advanced Prostate Cancer 70 By Phillip Ramati 70 Initiate Phase 70 Significantly Increases 70 Increases Risk 70 Study Indicates 70 Regulatory Disclosure 70 Joint Surg Am 70 Cancer Treatments 70 Recombinant Human 70 J Clin 70 Immune Cells 70 Malaria Vaccine 70 Issues Guidance 70 Vertex Pharmaceuticals Announces 70 Obstet Gynecol 70 Study Identifies 70 Arch Neurol 69 Phase III Trial 69 Anemia Drugs 69 J Pediatr 69 Study Examines 69 J Am Acad 69 Breast Cancer Treatment 69 Ann Oncol 69 Above Consensus 69 Chronic Hepatitis B 69 Renal Cell Carcinoma 69 Pomerantz Law Firm 69 Am J Obstet 69 Weight Loss Drug 69 By Neil Osterweil 69 Pivotal Phase III

Back to home page